Skip to main content

Table 4 Viral load, RVR, ETR &SVR in Group 1 and Group 2 (Per Protocol-Analysis)

From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

 Viral load detectable
Group 1(n = 15)Group 2 (n = 17)
NoYesNoYes
N (%)N (%)N (%)N (%)
4th Week (RVR)14 (93.4)1 (6.6)15 (88.3)2 (11.7)
8th Week15 (100)0 (0)17 (100)0 (0)
12th Week (ETR)15 (100)0 (0)17 (100)0 (0)
24th Week (SVR)15 (100)0 (0)14 (82.3)3 (17.7)